BPMC

Blueprint Medicines
BPMC

Overview Fund Activity
Delisted

BPMC was delisted on the 17th of July, 2025.

Back to rankings

220 hedge funds and large institutions have $4.68B invested in Blueprint Medicines in 2019 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 94 increasing their positions, 46 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
220
Holders Change
+17
Holders Change %
+8.37%
% of All Funds
4.79%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.17%
New
54
Increased
94
Reduced
46
Closed
34
Calls
$63.8M
Puts
$40.2M
Net Calls
+$23.6M
Net Calls Change
+$25.6M

Top Buyers

1
Invesco
1
Invesco
Georgia
$170M
2
BlackRock
2
BlackRock
New York
$388M
3
HM
3
HealthCor Management
New York
$36.1M
4
CCM
4
Cadian Capital Management
New York
$49.4M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$404M

Top Sellers

1
PHS
1
PFM Health Sciences
California
$0
2
TGI
2
TRV GP II
Massachusetts
$0
3
MWNA
3
Marshall Wace North America
New York
$0
4
LCM
4
Laurion Capital Management
New York
$0
5
CH
5
CVI Holdings
Delaware
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PAMU
26
Pictet Asset Management (UK)
United Kingdom
$43.5M -$10.6M -112,838 -20%
BI
27
BVF Inc
California
$41.3M -$12M -127,400 -23%
American Century Companies
28
American Century Companies
Missouri
$37.7M +$6.18M +65,488 +20%
DM
29
Deerfield Management
New York
$36.9M -$10.9M -115,611 -23%
HM
30
HealthCor Management
New York
$36.1M +$36.1M +382,504 New
Loomis, Sayles & Company
31
Loomis, Sayles & Company
Massachusetts
$35.4M +$425K +4,501 +1%
GTC
32
Ghost Tree Capital
New York
$35.4M +$12.7M +135,000 +56%
Goldman Sachs
33
Goldman Sachs
New York
$33.2M -$4.69M -49,729 -12%
CAM
34
Cormorant Asset Management
Massachusetts
$33M -$9.43M -100,000 -22%
Deutsche Bank
35
Deutsche Bank
Germany
$29.3M +$14M +148,811 +92%
RSCM
36
Rock Springs Capital Management
Maryland
$29M +$3.07M +32,500 +12%
Charles Schwab
37
Charles Schwab
California
$27M +$3.79M +40,225 +16%
Brown Advisory
38
Brown Advisory
Maryland
$25.9M +$3.49M +36,972 +16%
VOYA Investment Management
39
VOYA Investment Management
Georgia
$23.5M -$7.67M -81,321 -25%
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$22.6M +$14.2M +150,365 +169%
Nuveen Asset Management
41
Nuveen Asset Management
Illinois
$21.2M +$20.1M +212,940 +1,857%
Two Sigma Investments
42
Two Sigma Investments
New York
$20.4M +$11.2M +118,313 +120%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$20.1M +$1.81M +19,206 +10%
Jennison Associates
44
Jennison Associates
New York
$17.7M -$35.2K -373 -0.2%
SSA
45
Schonfeld Strategic Advisors
New York
$13.5M +$2.03M +21,500 +18%
Federated Hermes
46
Federated Hermes
Pennsylvania
$13.5M +$13.5M +142,754 New
NHAS
47
Novo Holdings A/S
Denmark
$12.5M +$6.17M +65,409 +97%
UBS AM
48
UBS AM
Illinois
$12.5M +$184K +1,953 +2%
OM
49
Opaleye Management
Massachusetts
$11.8M -$472K -5,000 -4%
Alkeon Capital Management
50
Alkeon Capital Management
New York
$11.8M – – –
1
2
3 4 5